A subchronic application period of glucocorticoids leads to rat cognitive dysfunction whereas physostigmine induces a mild neuroprotection

Journal of Neural Transmission

Volumn 117, Issue 9, 2010, Pages 1055-1065

  Wüppen, Katrin ^a   Oesterle, Dirk ^a   Lewicka, Sabina ^a   Kopitz, Jürgen ^a   Plaschke, Konstanze ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acetylcholine; Acetylcholinesterase; Cognition; Glucocorticoid induced stress; Physostigmine

Indexed keywords

ACETYLCHOLINESTERASE; CORTICOSTERONE; PHYSOSTIGMINE; ACETYLCHOLINE;

ACETYLCHOLINE BRAIN LEVEL; ADRENAL GLAND; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS ANALYSIS; BODY MASS; BRAIN CORTEX; BRAIN TISSUE; CHOLINERGIC TRANSMISSION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ESCAPE LATENCY; HIPPOCAMPUS; MALE; MAZE TEST; MORRIS WATER MAZE TEST; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PSYCHOMETRY; RAT; SPATIAL LEARNING; SPATIAL MEMORY; ANALYSIS OF VARIANCE; ANIMAL; ASSOCIATION; DRUG EFFECT; MEMORY; METABOLISM; RADIOIMMUNOASSAY; RANDOMIZATION; WISTAR RAT;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; COGNITION; CORTICOSTERONE; CUES; MALE; MAZE LEARNING; MEMORY; PHYSOSTIGMINE; RADIOIMMUNOASSAY; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 85027920819     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0441-4     Document Type: Article

References (64)

1. Aracava Y, Deshpande SS, Rickett DL, Brossi A, Schonenberger B, Albuquerque EX (1987) The molecular basis of anticholinesterase actions on nicotinic and glutamatergic synapses. Ann NY Acad Sci 505:226–255
2. Bardgett ME, Taylor GT, Csernansky JG, Newcomer JW, Nock B (1994) Chronic corticosterone treatment impairs spontaneous alternation behavior in rats. Behav Neural Biol 61:186–190
3. Bertrand D, Valera S, Bertrand S, Ballivet M, Rungger D (1991) Steroids inhibit nicotinic acetylcholine receptors. Neuroreport 2:277–280
4. Birks J (2006) Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev CD005593
5. Braun S, Askanas V, Engel WK, Ibrahim EN (1993) Long-term treatment with glucocorticoids increases synthesis and stability of junctional acetylcholine receptors on innervated cultured human muscle. J Neurochem 60:1929–1935
6. Brown DV, Heller F, Barkin R (2004) Anticholinergic syndrome after anesthesia: a case report and review. Am J Ther 11:144–153
7. Coburn-Litvak PS, Pothakos K, Tata DA, McCloskey DP, Anderson BJ (2003) Chronic administration of corticosterone impairs spatial reference memory before spatial working memory in rats. Neurobiol Learn Mem 80:11–23
8. Coelho F, Birks J (2001) Physostigmine for Alzheimer’s disease. Cochrane Database Syst Rev CD001499
9. Dai J, Buijs R, Swaab D (2004) Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer’s disease. Br J Pharmacol 143:606–610
10. de Haan M, van Herck H, Tolboom JB, Beynen AC, Remie R (2002) Endocrine stress response in jugular-vein cannulated rats upon multiple exposure to either diethyl-ether, halothane/O2/N2O or sham anaesthesia. Lab Anim 36:105–114
11. de Kloet ER, Oitzl MS, Joels M (1999) Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci 22:422–426
12. De Sarno P, Giacobini E (1989) Modulation of acetylcholine release by nicotinic receptors in the rat brain. J Neurosci Res 22:194–200
13. de Quervain DJ, Poirier R, Wollmer MA, Grimaldi LM, Tsolaki M, Streffer JR, Hock C, Nitsch RM, Mohajeri MH, Papassotiropoulos A (2004) Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet 13:47–52
14. Diamond DM, Park CR, Heman KL, Rose GM (1999) Exposing rats to a predator impairs spatial working memory in the radial arm water maze. Hippocampus 9:542–552
15. Erb C, Troost J, Kopf S, Schmitt U, Loffelholz K, Soreq H, Klein J (2001) Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J Neurochem 77:638–646
16. Feldmann RE Jr, Maurer MH, Hunzinger C, Lewicka S, Buergers HF, Kalenka A, Hinkelbein J, Broemme JO, Seidler GH, Martin E, Plaschke K (2008) Reduction in rat phosphatidylethanolamine binding protein-1 (PEBP1) after chronic corticosterone treatment may be paralleled by cognitive impairment: a first study. Stress 11:134–147
17. Flood JF, Vidal D, Bennett EL, Orme AE, Vasquez S, Jarvik ME (1978) Memory facilitating and anti-amnesic effects of corticosteroids. Pharmacol Biochem Behav 8:81–87
18. Goto K, Chiba Y, Sakai H, Misawa M (2008) Glucocorticoids inhibited airway hyperresponsiveness through downregulation of CPI-17 in bronchial smooth muscle. Eur J Pharmacol 591:231–236
19. Hauger RL, Millan MA, Catt KJ, Aguilera G (1987) Differential regulation of brain and pituitary corticotropin-releasing factor receptors by corticosterone. Endocrinology 120:1527–1533
20. Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, Lupien SJ, Roozendaal B, Seckl JR (2006) Do corticosteroids damage the brain? J Neuroendocrinol 18:393–411
21. Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, Mautner S, Wente MN, Encke J, Werner J, Dalpke AH, Stremmel W, Nawroth PP, Martin E, Krammer PH, Bierhaus A, Weigand MA (2008) Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med 36:404–408
22. Holsboer F, Barden N (1996) Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 17:187–205
23. Joels M, Pu Z, Wiegert O, Oitzl MS, Krugers HJ (2006) Learning under stress: how does it work? Trends Cogn Sci 10:152–158
24. Karssen AM, Meijer OC, van der Sandt IC, Lucassen PJ, de Lange EC, de Boer AG, de Kloet ER (2001) Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 142:2686–2694
25. Karuri AR, Engelking LR, Kumar MS (1998) Effects of halothane and methoxyflurane on the hypothalamic-pituitary-adrenal axis in rat. Brain Res Bull 47:205–209
26. Kaufer D, Friedman A, Seidman S, Soreq H (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393:373–377
27. Kaufer D, Friedman A, Seidman S, Soreq H (1999) Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission. Chem Biol Interact 119–120:349–360
28. Li Y, Camp S, Rachinsky TL, Bongiorno C, Taylor P (1993) Promoter elements and transcriptional control of the mouse acetylcholinesterase gene. J Biol Chem 268:3563–3572
29. Maelicke A, Coban T, Schrattenholz A, Schroder B, Reinhardt-Maelicke S, Storch A, Godovac-Zimmermann J, Methfessel C, Pereira EF, Albuquerque EX (1993) Physostigmine and neuromuscular transmission. Ann NY Acad Sci 681:140–154
30. Mandel RJ, Thal LJ (1988) Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats. Psychopharmacology (Berl) 96:421–425
31. Marklund N, Peltonen M, Nilsson TK, Olsson T (2004) Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med 256:15–21
32. McEwen BS, Sapolsky RM (1995) Stress and cognitive function. Curr Opin Neurobiol 5:205–216
33. Meshorer E, Erb C, Gazit R, Pavlovsky L, Kaufer D, Friedman A, Glick D, Ben-Arie N, Soreq H (2002) Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295:508–512
34. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47–60
35. Murialdo G, Nobili F, Rollero A, Gianelli MV, Copello F, Rodriguez G, Polleri A (2000) Hippocampal perfusion and pituitary-adrenal axis in Alzheimer’s disease. Neuropsychobiology 42:51–57
36. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME (1994) Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 14:2047–2053
37. O’Brien JT, Ames D, Schweitzer I, Colman P, Desmond P, Tress B (1996) Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer’s disease. Br J Psychiatry 168:679–687
38. Osmanovic J, Plaschke K, Salkovic-Petrisic M, Grunblatt E, Riederer P, Hoyer S (2010) Chronic exogenous corticosterone administration generates an insulin-resistant brain state in rats. Stress 13:123–131
39. Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75–111
40. Pinnock SB, Herbert J (2001) Corticosterone differentially modulates expression of corticotropin releasing factor and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus following either acute or repeated restraint stress. Eur J Neurosci 13:576–584
41. Plaschke K, Feindt J, Djuric Z, Heiland S, Autschbach F, Lewicka S, Martin E, Bardenheuer HJ, Nawroth PP, Bierhaus A (2006) Chronic corticosterone-induced deterioration in rat behaviour is not paralleled by changes in hippocampal NF-kappaB-activation. Stress 9:97–106
42. Plaschke K, Staub J, Ernst E, Marti HH (2008) VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp Neurol 214:285–292
43. Plaschke K, Frauenknecht K, Sommer C, Heiland S (2009) A single systemic transient hypotension induces long-term changes in rats’ MRI parameters and behavior: relation to aging. Neurol Res 31:304–312
44. Plotsky PM, Owens MJ, Nemeroff CB (1998) Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 21:293–307
45. Rhodes ME, O’Toole SM, Wright SL, Czambel RK, Rubin RT (2001) Sexual diergism in rat hypothalamic-pituitary-adrenal axis responses to cholinergic stimulation and antagonism. Brain Res Bull 54:101–113
46. Riley EP, Barron S, Driscoll CD, Hamlin RT (1986) The effects of physostigmine on open-field behavior in rats exposed to alcohol prenatally. Alcohol Clin Exp Res 10:50–53
47. Sadowski RN, Jackson GR, Wieczorek L, Gold PE (2009) Effects of stress, corticosterone, and epinephrine administration on learning in place and response tasks. Behav Brain Res 205:19–25
48. Sandi C (2004) Stress, cognitive impairment and cell adhesion molecules. Nat Rev Neurosci 5:917–930
49. Sandi C, Loscertales M (1999) Opposite effects on NCAM expression in the rat frontal cortex induced by acute vs chronic corticosterone treatments. Brain Res 828:127–134
50. Shaked I, Zimmerman G, Soreq H (2008) Stress-induced alternative splicing modulations in brain and periphery: acetylcholinesterase as a case study. Ann NY Acad Sci 1148:269–281
51. Shapira M, Tur-Kaspa I, Bosgraaf L, Livni N, Grant AD, Grisaru D, Korner M, Ebstein RP, Soreq H (2000) A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum Mol Genet 9:1273–1281
52. Somani SM, Khalique A (1986) Distribution and pharmacokinetics of physostigmine in rat after intramuscular administration. Fundam Appl Toxicol 6:327–334
53. Somani SM, Khalique A (1987) Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration. Drug Metab Dispos 15:627–633
54. Sternfeld M, Shoham S, Klein O, Flores-Flores C, Evron T, Idelson GH, Kitsberg D, Patrick JW, Soreq H (2000) Excess “read-through” acetylcholinesterase attenuates but the “synaptic” variant intensifies neurodeterioration correlates. Proc Natl Acad Sci USA 97:8647–8652
55. Stratakis CA, Chrousos GP (1995) Neuroendocrinology and pathophysiology of the stress system. Ann NY Acad Sci 771:1–18
56. Treit D, Fundytus M (1988) Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 31:959–962
57. van Dyck CH, Newhouse P, Falk WE, Mattes JA (2000) Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment Physostigmine Study Group. Arch Gen Psychiatry 57:157–164
58. van Marum RJ (2008) Current and future therapy in Alzheimer’s disease. Fundam Clin Pharmacol 22:265–274
59. Vanitallie TB (2002) Stress: a risk factor for serious illness. Metabolism 51:40–45
60. Vecsei P (1979) Glucocorticoids: cortisol, cortisone, corticosterone, compound S and their metabolites. In: Jaffe BM, Behrmann HR (eds) Methods of hormone radioimmunoassays. Academic Press, New York, pp 767–792
61. Vollmayr B, Faust H, Lewicka S, Henn FA (2001) Brain-derived-neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness. Mol Psychiatry 6:471–474, 358
62. Wolf OT (2003) HPA axis and memory. Best Pract Res Clin Endocrinol Metab 17:287–299
63. Woolley CS, Gould E, McEwen BS (1990) Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 531:225–231
64. Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1999) The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl) 145:260–266